Articles with "cardiovascular adverse" as a keyword



Photo from academic.microsoft.com

Time‐dependent trends in cardiovascular adverse events during follow‐up after carotid or iliofemoral endarterectomy

Sign Up to like & get
recommendations!
Published in 2017 at "British Journal of Surgery"

DOI: 10.1002/bjs.10576

Abstract: Recent observations have suggested a decline in vulnerable carotid artery and iliofemoral atherosclerotic plaque characteristics over the past decade. The aim of this study was to determine whether, in the presence of clinically manifest carotid… read more here.

Keywords: cardiovascular adverse; trends cardiovascular; events follow; dependent trends ... See more keywords
Photo from academic.microsoft.com

CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Clinical Laboratory Analysis"

DOI: 10.1002/jcla.22369

Abstract: This study was aimed to investigate the correlation between CYP2C19 and ABCB1 polymorphisms and the recurrence of ischemic cardiovascular adverse events in patients with coronary artery disease treated with clopidogrel. read more here.

Keywords: recurrence ischemic; cardiovascular adverse; cyp2c19 abcb1; adverse events ... See more keywords
Photo by lgnwvr from unsplash

Sunitinib does not acutely alter left ventricular systolic function, but induces diastolic dysfunction

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer Chemotherapy and Pharmacology"

DOI: 10.1007/s00280-018-3593-9

Abstract: PurposeCancer chemotherapies have improved the prognosis of cancer patients in recent years; however, their side effects on the cardiovascular systems have emerged as a major concern in the field of both cardiology and oncology. In… read more here.

Keywords: cardiovascular adverse; sunitinib; cardiac troponin; adverse events ... See more keywords
Photo from wikipedia

Novel glucose lowering agents are associated with a lower risk of cardiovascular and adverse events in type 2 diabetes: A population based analysis.

Sign Up to like & get
recommendations!
Published in 2020 at "International journal of cardiology"

DOI: 10.1016/j.ijcard.2020.03.025

Abstract: BACKGROUND Recent randomized control trials have described a protective cardiovascular effect of novel glucose lowering drugs in patients at high cardiovascular risk. Whether these second-line agents have similar effects in the general population is unknown.… read more here.

Keywords: second line; cardiovascular adverse; risk; novel glucose ... See more keywords
Photo from wikipedia

Gastrointestinal and cardiovascular adverse events associated with NSAIDs.

Sign Up to like & get
recommendations!
Published in 2021 at "Expert opinion on drug safety"

DOI: 10.1080/14740338.2021.1965988

Abstract: INTRODUCTION Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most prescribed pharmacological groups, especially in elderly patients.Areas Covered: The main GI and CV adverse events associated with NSAID use are reviewed. Risk factors and prophylactic… read more here.

Keywords: cardiovascular adverse; upper lower; cox selective; events associated ... See more keywords
Photo from wikipedia

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Internal Medicine"

DOI: 10.1111/joim.12882

Abstract: The novel proteasome inhibitor carfilzomib alone or in combination with other agents is already one of the standard therapies for relapsed and/or refractory multiple myeloma (MM) patients and produces impressive response rates in newly diagnosed… read more here.

Keywords: cardiovascular adverse; myeloma; treatment; myeloma patients ... See more keywords
Photo from wikipedia

Association between antipsychotics and cardiovascular adverse events: A systematic review.

Sign Up to like & get
recommendations!
Published in 2017 at "Revista da Associacao Medica Brasileira"

DOI: 10.1590/1806-9282.63.03.261

Abstract: Objective: Determine whether there is an association between the risk of cardiovascular adverse events and the use of antipsychotic agents. Method: Analysis of original articles retrieved from the following databases: LILACS, PubMed, Cochrane Controlled Trials… read more here.

Keywords: events systematic; cardiovascular adverse; association antipsychotics; adverse events ... See more keywords
Photo from wikipedia

Clinical Features of Patients Presenting to the Emergency Department With Cardiovascular Adverse Reactions After COVID-19 mRNA Vaccination

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Korean Medical Science"

DOI: 10.3346/jkms.2022.37.e73

Abstract: Background Since the implementation of the nationwide coronavirus disease 2019 (COVID-19) vaccination campaign, emergency departments (EDs) have had an increasing number of patients reporting postvaccination cardiovascular adverse effects. We investigated the clinical features of patients… read more here.

Keywords: reactions covid; mrna vaccination; adverse reactions; cardiovascular adverse ... See more keywords
Photo from wikipedia

Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Cardiovascular Medicine"

DOI: 10.3389/fcvm.2022.966182

Abstract: Objective The aim of this article is to assess the risk and potential mechanisms of cardiovascular adverse events in patients treated with nilotinib or imatinib by conducting a systematic review, meta-analysis and integrative bioinformatics analysis.… read more here.

Keywords: bioinformatics analysis; patients treated; cardiovascular adverse; analysis ... See more keywords
Photo by charlesdeluvio from unsplash

Cardiovascular adverse events induced by immune checkpoint inhibitors: A real world study from 2018 to 2022

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Cardiovascular Medicine"

DOI: 10.3389/fcvm.2022.969942

Abstract: Background The reported rate of cardiovascular adverse events (CAE) caused by immune checkpoint inhibitors (ICI) is low but potentially fatal. Assess the risk of CAE in cancer patients and compare the incidence of CAE between… read more here.

Keywords: checkpoint inhibitors; immune checkpoint; cae; cardiovascular adverse ... See more keywords

Establishing plausibility of cardiovascular adverse effects of immunotherapies using Mendelian randomisation

Sign Up to like & get
recommendations!
Published in 2023 at "Frontiers in Cardiovascular Medicine"

DOI: 10.3389/fcvm.2023.1116799

Abstract: Immune checkpoint inhibitors (ICIs) and Janus kinase inhibitors (JAKis) have raised concerns over serious unexpected cardiovascular adverse events. The widespread pleiotropy in genome-wide association studies offers an opportunity to identify cardiovascular risks from in-development drugs… read more here.

Keywords: stroke risk; cardiovascular adverse; risk; ischemic stroke ... See more keywords